CD200 dysregulation in asthma: potential for therapy?

哮喘中的 CD200 失调：治疗潜力？

• 批准号: 356406
• 负责人: Bissonnette Elyse
• 金额: $ 46.81万
• 依托单位: Institut universitaire de cardiologie et de pneumologie de Qubec - U Laval
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2021-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=356406&lang=en
• 关键词: Alveolar Macrophages; Animal Lung Function; Cd200/Cd200r Pathway; Cytokines; Dendritic Cells; Human Bronchoalveolar Lavage; Inflammatory Responses; Rat Animal Model Of Asthma

Our lungs are relentlessly bombarded by foreign particles and must continually work hard to discriminate between dangerous and harmless ones. Considering the volume of allergen-filled air inhaled every day, the prevalence of inflammation and lung diseases

我们的肺被外来颗粒无情地轰炸，必须不断努力区分危险和无害的。考虑到每天吸入的充满过敏原的空气量，炎症和肺部疾病的患病率